Yang Liu and Keda Zhou

Meet DNA’s chaperone

Nov. 26, 2019

Researchers have discovered the structure of the FACT protein—a mysterious protein central to the functioning of DNA

xeudong liu

Lab Venture Challenge

Nov. 19, 2019

Lab Venture Challenge awards $900,000 to promising bioscience, physical science and engineering ventures

Students standing in front of JSCBB

BSI welcomes a new cohort of BSI Scholars

Oct. 10, 2019

Congratulations to new and continuing undergraduate BSI scholars researching in Biochemistry labs! These students are working on a diverse range of projects here at the Jennie Smoly Caruthers Biotechnology Building. Undergraduates pictured: Lisa Hansen ( Batey Lab ), Bobby Meushaw and John Moir ( Taatjes Lab ), Tara Jourabchi (...

Tom Cech

Faculty in Focus: Tom Cech looks back on Nobel Prize in chemistry

Oct. 8, 2019

It’s been 30 years since CU Boulder Distinguished Professor Tom Cech received the 1989 Nobel Prize in chemistry for his findings that RNA in living cells is not only a molecule that encodes information but can also function as a catalyst. His discovery laid the foundation for advances in molecular...

Three women doing lab research

CU Boulder attracts a record $631 million in annual research funding

Oct. 7, 2019

CU Boulder research attracted a record $631 million in funding in fiscal year 2019 for groundbreaking studies that investigate a changing environment, explore new opportunities in space, mitigate the effects of natural hazards, advance biomedical research and seek cleaner, more sustainable energy solutions.


The unexpected complexities of TERT, a key cancer driver

Sept. 11, 2019

Telomerase reverse transcriptase (TERT), an enzyme associated with nearly all malignant human cancers, is even more diverse and unconventional than previously realized according to new research by CU Biochem and BioFrontiers' Distinguished Professor Thomas Cech and Professor John Rinn.

double helix graphic

A key ‘kill switch’ in a gene-regulating protein group

Sept. 9, 2019

CU Boulder and Howard Hughes Medical Institute (HHMI) biochemists have revealed a key regulatory process in a gene-suppressing protein group that could hold future applications for drug discovery and clinical treatment of diseases, including cancer.


CU Boulder spinout OnKure Therapeutics enrolls first cancer patient in clinical trial

June 19, 2019

A new drug therapy for cancer treatment, spun out of research performed in a CU Boulder biochemistry lab , may provide better results for patients with solid cancers and hematologic cancers, such as leukemia and lymphoma.

Sabrina Spencer

Biochemist wins top award for study of cellular proliferation

Oct. 5, 2018

NIH’s High-Risk, High-Reward Research program to fund Sabrina Spencer’s CU Boulder research that could shed light on cancer treatment Scientists do not fully understand how cells choose between proliferation and quiescence (a state of non-proliferation) but a University of Colorado Boulder biochemist’s novel proposal to study the issue has won...

Board of Regents

Regents approve the split of the Department of Chemistry and Biochemistry into separate departments

June 25, 2018

The board voted by consent agenda to split the CU Boulder Department of Chemistry and Biochemistry into two independent departments: the Department of Chemistry and the Department of Biochemistry.